据悉,于美东时间3月18日上午10点,Neos治疗将召开股东会议,以投票批准与Aytu进行合并的提案。每股获0.1088股的Aytu股票。
NEOS治疗公司是一家制药公司,专注...查看全文
Linktu2021-02-16 06:59
$Neos治疗(NEOS)$ 在合并结束时,合并后的公司将改名为Aytu生物制药公司 -
科罗拉多州恩格伍德和德克萨斯州大草原市/ 2021年2月10日/专业化制药公司Aytu BioScience,Inc.(纳斯达克股票代码:AYTU)和Neos Therapeutics,Inc.(纳斯达克股票代码:致力于满足重要患者需求的新型产品的商业化)...查看全文
美股狙击2021-02-11 18:48
$Castor Maritime(CTRM)$ $箩筐技术(LKCO)$ $Neos治疗(NEOS)$ 祝大家牛年大发,牛气冲天,身体壮如牛,买啥啥都牛,牛牛牛!查看全文
$Neos Therapeutics, Inc.(NEOS)$ 8-K - Current report Filed: 2017-06-05 AccNo: 0001104659-17-037350 Size: 17 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Neos Therapeutics, Inc.(NEOS)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2017-05-10 AccNo: 0001104659-17-031314 Size: 5 MB 网页链接
$Neos Therapeutics, Inc.(NEOS)$ 8-K - Current report Filed: 2017-05-09 AccNo: 0001104659-17-030925 Size: 163 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Neos Therapeutics, Inc.(NEOS)$ 美东时间 2017-05-09 盘前 披露财报,预期EPS -0.89 网页链接
$Neos Therapeutics, Inc.(NEOS)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2017-04-28 AccNo: 0001104659-17-027234 Size: 192 KB 网页链接
$Neos Therapeutics, Inc.(NEOS)$ DEF 14A - Other definitive proxy statements Filed: 2017-04-28 AccNo: 0001047469-17-003021 Size: 836 KB 网页链接
$Neos Therapeutics, Inc.(NEOS)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-04-14 AccNo: 0001104659-17-023572 Size: 125 KB 网页链接
$Neos Therapeutics, Inc.(NEOS)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-03-15 AccNo: 0001104659-17-016446 Size: 95 KB 网页链接
$Neos Therapeutics, Inc.(NEOS)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-15 AccNo: 0001047469-17-001586 Size: 13 MB 网页链接
$Neos Therapeutics, Inc.(NEOS)$ 8-K - Current report Filed: 2017-03-14 AccNo: 0001104659-17-016247 Size: 187 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接